Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""rejection"" wg kryterium: Temat


Tytuł :
Early critical cortical infarction by anti-angiotensin II type 1 receptor antibody: A case report and literature review.
Autorzy :
Lim JH; Department of Internal Medicine.
Han MH; Department of Pathology.
Kim YJ; Department of Pathology.
Huh S; Department of Surgery, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, South Korea.
Kim CD; Department of Internal Medicine.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 May 28; Vol. 100 (21), pp. e25958.
Typ publikacji :
Case Reports; Journal Article; Review
MeSH Terms :
Graft Rejection/*immunology
Infarction/*immunology
Isoantibodies/*blood
Kidney Cortex Necrosis/*immunology
Kidney Transplantation/*adverse effects
Receptor, Angiotensin, Type 1/*immunology
Allografts/blood supply ; Allografts/immunology ; Allografts/pathology ; Female ; Graft Rejection/blood ; Graft Rejection/diagnosis ; Graft Rejection/therapy ; Histocompatibility Testing ; Humans ; Immunologic Factors/administration & dosage ; Infarction/blood ; Infarction/diagnosis ; Infarction/therapy ; Isoantibodies/immunology ; Kidney Cortex/blood supply ; Kidney Cortex/immunology ; Kidney Cortex/pathology ; Kidney Cortex Necrosis/blood ; Kidney Cortex Necrosis/diagnosis ; Kidney Cortex Necrosis/therapy ; Kidney Failure, Chronic/surgery ; Living Donors ; Male ; Middle Aged ; Plasmapheresis ; Spouses ; Time Factors
Czasopismo naukowe
Tytuł :
CD38 Antibody Daratumumab for the Treatment of Chronic Active Antibody-mediated Kidney Allograft Rejection.
Autorzy :
Doberer K; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Kläger J; Department of Pathology, Medical University of Vienna, Vienna, Austria.
Gualdoni GA; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Mayer KA; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.; Institute of Immunology, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Eskandary F; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Farkash EA; Department of Pathology and Clinical Laboratories, University of Michigan Health System, Ann Arbor, MI.
Agis H; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Reiter T; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Reindl-Schwaighofer R; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Wahrmann M; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Cohen G; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Haslacher H; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Bond G; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Simonitsch-Klupp I; Department of Pathology, Medical University of Vienna, Vienna, Austria.
Halloran PF; Alberta Transplant Applied Genomics Centre, ATAGC, University of Alberta, Edmonton, AB, Canada.
Böhmig GA; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2021 Feb 01; Vol. 105 (2), pp. 451-457.
Typ publikacji :
Case Reports
MeSH Terms :
Antibodies, Monoclonal/*therapeutic use
Graft Rejection/*drug therapy
HLA Antigens/*immunology
Immunosuppressive Agents/*therapeutic use
Isoantibodies/*blood
Kidney Transplantation/*adverse effects
Killer Cells, Natural/*drug effects
Plasma Cells/*drug effects
Chronic Disease ; Graft Rejection/blood ; Graft Rejection/immunology ; Graft Survival/drug effects ; Humans ; Immunity, Cellular/drug effects ; Immunity, Humoral/drug effects ; Killer Cells, Natural/immunology ; Killer Cells, Natural/metabolism ; Male ; Middle Aged ; Plasma Cells/immunology ; Plasma Cells/metabolism ; Treatment Outcome
Raport
Tytuł :
The Impact of Inadequate ("AX") Transbronchial Biopsies on Post-lung Transplant CLAD or Death.
Autorzy :
Levy L; Toronto Lung Transplant Program, University Health Network, University of Toronto, Toronto, ON, Canada.; Institute of Pulmonary Medicine, Sheba Medical Center, Affiliated with Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Huszti E; Biostatistics Research Unit, University Health Network, University of Toronto, Toronto, ON, Canada.
Pal P; Department of Pathology, University Health Network, University of Toronto, Toronto, ON, Canada.
Tikkanen J; Toronto Lung Transplant Program, University Health Network, University of Toronto, Toronto, ON, Canada.
Ghany R; Toronto Lung Transplant Program, University Health Network, University of Toronto, Toronto, ON, Canada.
Keshavjee S; Toronto Lung Transplant Program, University Health Network, University of Toronto, Toronto, ON, Canada.
Martinu T; Toronto Lung Transplant Program, University Health Network, University of Toronto, Toronto, ON, Canada.
Singer LG; Toronto Lung Transplant Program, University Health Network, University of Toronto, Toronto, ON, Canada.
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2021 Feb 01; Vol. 105 (2), pp. 390-395.
Typ publikacji :
Journal Article
MeSH Terms :
Graft Rejection/*pathology
Lung/*surgery
Lung Diseases/*pathology
Lung Transplantation/*adverse effects
Adult ; Biopsy ; Chronic Disease ; Female ; Forced Expiratory Volume ; Graft Rejection/mortality ; Graft Rejection/physiopathology ; Graft Rejection/therapy ; Humans ; Lung/pathology ; Lung/physiopathology ; Lung Diseases/mortality ; Lung Diseases/physiopathology ; Lung Diseases/therapy ; Lung Transplantation/mortality ; Male ; Middle Aged ; Predictive Value of Tests ; Reproducibility of Results ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Anti-pig IgE and IgA Antibodies in Naive Primates and Nonhuman Primates With Pig Xenografts.
Autorzy :
Li Q; Xenotransplantation Program, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL.; General Hospital of Southern Theater Command, PLA, Guangzhou, China.
Iwase H; Xenotransplantation Program, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL.
Yamamoto T; Xenotransplantation Program, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL.
Nguyen HQ; Xenotransplantation Program, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL.
Ayares D; Revivicor, Blacksburg, VA.
Wang Y; The Second Affiliated Hospital of Hainan Medical University, Hainan, China.; The Transplantation Institute of Hainan Medical University, Hainan, China.
Cooper DKC; Xenotransplantation Program, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL.
Hara H; Xenotransplantation Program, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL.
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2021 Feb 01; Vol. 105 (2), pp. 318-327.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Heterophile/*blood
Erythrocytes/*immunology
Graft Rejection/*immunology
Immunoglobulin A/*blood
Immunoglobulin E/*blood
Transplantation, Heterologous/*adverse effects
Animals ; Animals, Genetically Modified ; Galactosyltransferases/genetics ; Galactosyltransferases/immunology ; Graft Rejection/blood ; Graft Rejection/pathology ; Humans ; Macaca mulatta ; Mixed Function Oxygenases/genetics ; Mixed Function Oxygenases/immunology ; N-Acetylgalactosaminyltransferases/genetics ; N-Acetylgalactosaminyltransferases/immunology ; Papio ; Species Specificity ; Sus scrofa/genetics ; Sus scrofa/immunology
Czasopismo naukowe
Tytuł :
Center-level Variation in HLA-incompatible Living Donor Kidney Transplantation Outcomes.
Autorzy :
Jackson KR; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Long J; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Motter J; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Bowring MG; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Chen J; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Waldram MM; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Orandi BJ; Department of Surgery, University of Alabama, Birmingham, AL.
Montgomery RA; The NYU Transplant Institute, New York University Langone Medical Center, New York, NY.
Stegall MD; Department of Surgery, Mayo Clinic, Rochester, MN.
Jordan SC; Department of Medicine, Cedars-Sinai Comprehensive Transplant Center, Los Angeles, CA.
Benedetti E; Department of Surgery, University of Illinois-Chicago, Chicago, IL.
Dunn TB; Department of Surgery, University of Pennsylvania, Philadelphia, PA.
Ratner LE; Department of Surgery, Columbia University Medical Center, New York, NY.
Kapur S; Department of Surgery, New York Presbyterian/Weill Cornell Medical Center, New York, NY.
Pelletier RP; Department of Surgery, Robert Wood Johnson University Hospital, New Brunswick, NJ.
Roberts JP; Department of Surgery, University of California-San Francisco, San Francisco, CA.
Melcher ML; Department of Surgery, Stanford University, Palo Alto, CA.
Singh P; Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA.
Sudan DL; Department of Surgery, Duke University Medical Center, Durham, NC.
Posner MP; Department of Surgery, Virginia Commonwealth University, Richmond, VA.
El-Amm JM; Integris Baptist Medical Center, Transplant Division, Oklahoma City, OK.
Shapiro R; Recanti Miller Transplantation Institute, Mount Sinai Hospital, New York, NY.
Cooper M; Medstar Georgetown Transplant Institute, Washington, DC.
Verbesey JE; Medstar Georgetown Transplant Institute, Washington, DC.
Lipkowitz GS; Department of Surgery, Baystate Medical Center Springfield, MA.
Rees MA; Department of Urology, University of Toledo Medical Center, Toledo, OH.
Marsh CL; Department of Surgery, Scripps Clinic and Green Hospital, La Jolla, CA.
Sankari BR; Department of Urology, Cleveland Clinic, Cleveland, OH.
Gerber DA; Department of Surgery, University of North Carolina School of Medicine, Chapel Hill, NC.
Wellen J; Department of Surgery, Barnes-Jewish Hospital, St. Louis, MO.
Bozorgzadeh A; Department of Surgery, University of Massachusetts Memorial Medical Center, Worcester, MA.
Gaber AO; Department of Surgery, Houston Methodist Hospital, Houston, TX.
Heher E; Department of Medicine, Massachusetts General Hospital, Boston, MA.
Weng FL; Renal and Pancreas Transplant Division, Saint Barnabas Medical Center, Livingston, NJ.
Djamali A; Department of Medicine, University of Wisconsin, Madison, WI.
Helderman JH; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
Concepcion BP; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
Brayman KL; Department of Surgery, University of Virginia, Charlottesville, VA.
Oberholzer J; Department of Surgery, University of Virginia, Charlottesville, VA.
Kozlowski T; Department of Surgery, University of Florida, Gainesville, FL.
Covarrubias K; Department of Surgery, University of California San Diego, San Diego, CA.
Desai N; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Massie AB; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Segev DL; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.; Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD.; Scientific Registry of Transplant Recipients, Minneapolis, MN.
Garonzik-Wang J; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2021 Feb 01; Vol. 105 (2), pp. 436-442.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Healthcare Disparities*
Histocompatibility*
Kidney Transplantation*/adverse effects
Kidney Transplantation*/mortality
Living Donors*
Practice Patterns, Physicians'*
Graft Rejection/*prevention & control
Graft Survival/*drug effects
HLA Antigens/*immunology
Immunosuppressive Agents/*therapeutic use
Isoantibodies/*blood
Adult ; Female ; Graft Rejection/blood ; Graft Rejection/immunology ; Graft Rejection/mortality ; Humans ; Immunosuppressive Agents/adverse effects ; Male ; Middle Aged ; Quality Indicators, Health Care ; Registries ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome ; United States
Czasopismo naukowe
Tytuł :
The Role of SLAs in Xenotransplantation.
Autorzy :
Ladowski JM; Xenotransplantation Program, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL.
Hara H
Cooper DKC
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2021 Feb 01; Vol. 105 (2), pp. 300-307.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Transplantation, Heterologous*/adverse effects
Antibodies, Heterophile/*blood
Antigens, Heterophile/*immunology
Graft Rejection/*immunology
Histocompatibility Antigens Class I/*immunology
Sus scrofa/*immunology
Animals ; Animals, Genetically Modified ; Antibody Specificity ; Antigens, Heterophile/genetics ; Graft Rejection/blood ; Graft Rejection/prevention & control ; Graft Survival ; Histocompatibility Antigens Class I/genetics ; Humans ; Species Specificity ; Sus scrofa/genetics ; Transplantation Tolerance
Czasopismo naukowe
Tytuł :
One for All and All for One: The Triumph of the One Study.
Autorzy :
Alexander SI; Centre for Kidney Research, Children's Hospital at Westmead, University of Sydney, NSW, Australia.
Hu M; Centre for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney, NSW, Australia.
O'Connell PJ; Centre for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney, NSW, Australia.
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2021 Feb 01; Vol. 105 (2), pp. 273-274.
Typ publikacji :
Editorial
MeSH Terms :
Adoptive Transfer*/adverse effects
Kidney Transplantation*/adverse effects
Transplantation Tolerance*
Graft Rejection/*prevention & control
Clinical Trials, Phase I as Topic ; Clinical Trials, Phase II as Topic ; Graft Rejection/immunology ; Graft Survival ; Humans ; Immunosuppressive Agents/therapeutic use ; Monitoring, Immunologic ; Non-Randomized Controlled Trials as Topic ; Treatment Outcome
Opinia redakcyjna
Tytuł :
Natural Killer Cells: Critical Effectors During Antibody-mediated Rejection of Solid Organ Allografts.
Autorzy :
Miyairi S; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
Baldwin WM 3rd
Valujskikh A
Fairchild RL
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2021 Feb 01; Vol. 105 (2), pp. 284-290.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms :
Immunity, Humoral*
Immunity, Innate*
Graft Rejection/*immunology
Isoantibodies/*blood
Killer Cells, Natural/*immunology
Organ Transplantation/*adverse effects
Animals ; Disease Models, Animal ; Graft Rejection/blood ; Humans ; Killer Cells, Natural/metabolism ; Phenotype ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Acute Corneal Endothelial Graft Rejection With Coinciding COVID-19 Infection.
Autorzy :
Jin SX; Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY.
Juthani VV
Pokaż więcej
Źródło :
Cornea [Cornea] 2021 Jan; Vol. 40 (1), pp. 123-124.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Keratoplasty, Penetrating*
SARS-CoV-2*
COVID-19/*diagnosis
Endothelium, Corneal/*pathology
Graft Rejection/*diagnosis
Keratoconus/*surgery
Acute Disease ; Adult ; COVID-19/etiology ; COVID-19 Testing ; Dysgeusia/diagnosis ; Female ; Graft Rejection/etiology ; Humans ; Polymerase Chain Reaction ; Reoperation ; Visual Acuity/physiology
Czasopismo naukowe
Tytuł :
Molecular Analysis of Renal Allograft Biopsies: Where Do We Stand and Where Are We Going?
Autorzy :
Snijders MLH; Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Varol H; Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
van der Zwan M; Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Becker JU; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
Hesselink DA; Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Rotterdam Transplant Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Baan CC; Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Rotterdam Transplant Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
von der Thüsen JH; Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Clahsen-van Groningen MC; Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Rotterdam Transplant Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2020 Dec; Vol. 104 (12), pp. 2478-2486.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Kidney Transplantation*/adverse effects
Molecular Diagnostic Techniques*
Pathology, Molecular*
Graft Rejection/*diagnosis
Immunity, Cellular/*genetics
Immunity, Humoral/*genetics
Kidney/*immunology
Biopsy, Large-Core Needle ; Genetic Predisposition to Disease ; Graft Rejection/genetics ; Graft Rejection/immunology ; Graft Rejection/pathology ; Humans ; Kidney/pathology ; Phenotype ; Predictive Value of Tests ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Mucosa and Rejection in Facial Vascularized Composite Allotransplantation: A Systematic Review.
Autorzy :
Kauke M; Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Safi AF; Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Zhegibe A; Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Haug V; Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Department of Hand, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg, Ludwigshafen, Germany.
Kollar B; Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Nelms L; Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Palmer WJ; Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Tchiloemba B; Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Lian CG; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Murphy GF; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Pomahac B; Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2020 Dec; Vol. 104 (12), pp. 2616-2624.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Composite Tissue Allografts/*transplantation
Facial Transplantation/*adverse effects
Graft Rejection/*immunology
Mucous Membrane/*transplantation
Skin/*immunology
Skin Transplantation/*adverse effects
Vascularized Composite Allotransplantation/*adverse effects
Adult ; Biopsy ; Composite Tissue Allografts/immunology ; Composite Tissue Allografts/pathology ; Female ; Graft Rejection/pathology ; Graft Rejection/therapy ; Graft Survival ; Humans ; Male ; Middle Aged ; Mucous Membrane/immunology ; Mucous Membrane/pathology ; Skin/pathology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Correlation between Venous Thromboembolism Risk and Venous Congestion in Microvascular Reconstruction of the Lower Extremity.
Autorzy :
Parham CS; From the Penn State Health Milton S. Hershey Medical Center.
Shen C; From the Penn State Health Milton S. Hershey Medical Center.
Pennock MM; From the Penn State Health Milton S. Hershey Medical Center.
Henderson SR; From the Penn State Health Milton S. Hershey Medical Center.
Kulaylat AS; From the Penn State Health Milton S. Hershey Medical Center.
Johnson TS; From the Penn State Health Milton S. Hershey Medical Center.
Pokaż więcej
Źródło :
Plastic and reconstructive surgery [Plast Reconstr Surg] 2020 Nov; Vol. 146 (5), pp. 1177-1185.
Typ publikacji :
Journal Article
MeSH Terms :
Graft Rejection/*epidemiology
Microvessels/*pathology
Postoperative Complications/*epidemiology
Reconstructive Surgical Procedures/*adverse effects
Venous Thromboembolism/*epidemiology
Adult ; Female ; Free Tissue Flaps/adverse effects ; Free Tissue Flaps/blood supply ; Free Tissue Flaps/transplantation ; Graft Rejection/etiology ; Graft Rejection/pathology ; Humans ; Lower Extremity/blood supply ; Lower Extremity/surgery ; Male ; Microvessels/transplantation ; Middle Aged ; Postoperative Complications/etiology ; Reconstructive Surgical Procedures/methods ; Retrospective Studies ; Risk Assessment ; Venous Thromboembolism/etiology ; Venous Thromboembolism/pathology ; Young Adult
Czasopismo naukowe
Tytuł :
Reducing Donor-specific Antibody During Acute Rejection Diminishes Long-term Renal Allograft Loss: Comparison of Early and Late Rejection.
Autorzy :
Lichvar AB; Department of Pharmacy Practice and Surgery, University of Illinois at Chicago, Chicago, IL.
Tremblay S; Department of Surgery, Division of Transplantation, University of Cincinnati, Cincinnati, OH.; Department of Environmental Health, Division of Epidemiology, University of Cincinnati, Cincinnati, OH.
Leino AD; Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH.
Shields AR; Department of Surgery, Division of Transplantation, University of Cincinnati, Cincinnati, OH.; The Christ Hospital, Cincinnati, OH.
Cardi MA; The Christ Hospital, Cincinnati, OH.
Abu Jawdeh BG; Department of Internal Medicine, Division of Nephrology, University of Cincinnati, Cincinnati, OH.
Govil A; Department of Internal Medicine, Division of Nephrology, University of Cincinnati, Cincinnati, OH.
Kremer J; The Christ Hospital, Cincinnati, OH.
Cuffy M; Department of Surgery, Division of Transplantation, University of Cincinnati, Cincinnati, OH.
Paterno F; Division of Liver Transplantation and Hepatobiliary Surgery, Rutgers New Jersey Medical School, Newark, NJ.
Diwan T; Department of Surgery, Division of Transplantation, University of Cincinnati, Cincinnati, OH.
Brailey P; Transplant Immunology Division, Hoxworth Blood Center, University of Cincinnati, Cincinnati, OH.
Girnita A; Transplant Immunology Division, Hoxworth Blood Center, University of Cincinnati, Cincinnati, OH.
Alloway RR; Department of Internal Medicine, Division of Nephrology, University of Cincinnati, Cincinnati, OH.
Woodle ES; Department of Surgery, Division of Transplantation, University of Cincinnati, Cincinnati, OH.
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2020 Nov; Vol. 104 (11), pp. 2403-2414.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Plasmapheresis*/adverse effects
Bortezomib/*therapeutic use
Graft Rejection/*therapy
Graft Survival/*drug effects
Immunosuppressive Agents/*therapeutic use
Isoantibodies/*blood
Kidney Transplantation/*adverse effects
Proteasome Inhibitors/*therapeutic use
Adult ; Biomarkers/blood ; Bortezomib/adverse effects ; Down-Regulation ; Female ; Graft Rejection/blood ; Graft Rejection/diagnosis ; Graft Rejection/immunology ; Humans ; Immunosuppressive Agents/adverse effects ; Male ; Middle Aged ; Phenotype ; Proteasome Inhibitors/adverse effects ; Retrospective Studies ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
A Clinical Trial With Adoptive Transfer of Ex Vivo-induced, Donor-specific Immune-regulatory Cells in Kidney Transplantation-A Second Report.
Autorzy :
Koyama I; Department of Surgery, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan.
Bashuda H; Atopy Research Center, Juntendo University Hospital, Juntendo University School of Medicine, Tokyo, Japan.
Uchida K; Atopy Research Center, Juntendo University Hospital, Juntendo University School of Medicine, Tokyo, Japan.
Seino KI; Division of immunobiology, Institute for genetic medicine, Hokkaido University, Sapporo, Japan.
Habu S; Atopy Research Center, Juntendo University Hospital, Juntendo University School of Medicine, Tokyo, Japan.
Nakajima I; Department of Surgery, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan.
Fuchinoue S; Department of Surgery, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan.
Okumura K; Atopy Research Center, Juntendo University Hospital, Juntendo University School of Medicine, Tokyo, Japan.
Teraoka S; Department of Transplant Surgery, Mita Hospital, International University of Health and Welfare, Tokyo, Japan.
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2020 Nov; Vol. 104 (11), pp. 2415-2423.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Adoptive Transfer*/adverse effects
Graft Survival*
Histocompatibility*
Kidney Transplantation*/adverse effects
Transplantation Tolerance*
Graft Rejection/*prevention & control
HLA Antigens/*immunology
T-Lymphocytes, Regulatory/*transplantation
Adult ; Cells, Cultured ; Coculture Techniques ; Combined Modality Therapy ; Female ; Graft Rejection/diagnosis ; Graft Rejection/immunology ; Humans ; Immunosuppressive Agents/therapeutic use ; Living Donors ; Lymphocyte Culture Test, Mixed ; Male ; Middle Aged ; Splenectomy ; T-Lymphocytes, Regulatory/immunology ; Time Factors ; Tokyo ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Noninvasive Monitoring of Deep Tissue Oxygenation in Buried Flaps by Time-Resolved Near-Infrared Spectroscopy in Pigs.
Autorzy :
Lartizien R; From the Service de Chirurgie Maxillo-faciale, Centre Hospitalier d'Annecy Genevois; INSERM-UGA U1209, CNRS UMR5309, Institute for Advanced Biosciences; and Université Grenoble Alpes, CEA, LETI, DTBS, LS2P.
Planat-Chrétien A; From the Service de Chirurgie Maxillo-faciale, Centre Hospitalier d'Annecy Genevois; INSERM-UGA U1209, CNRS UMR5309, Institute for Advanced Biosciences; and Université Grenoble Alpes, CEA, LETI, DTBS, LS2P.
Berger M; From the Service de Chirurgie Maxillo-faciale, Centre Hospitalier d'Annecy Genevois; INSERM-UGA U1209, CNRS UMR5309, Institute for Advanced Biosciences; and Université Grenoble Alpes, CEA, LETI, DTBS, LS2P.
Henry M; From the Service de Chirurgie Maxillo-faciale, Centre Hospitalier d'Annecy Genevois; INSERM-UGA U1209, CNRS UMR5309, Institute for Advanced Biosciences; and Université Grenoble Alpes, CEA, LETI, DTBS, LS2P.
Coll JL; From the Service de Chirurgie Maxillo-faciale, Centre Hospitalier d'Annecy Genevois; INSERM-UGA U1209, CNRS UMR5309, Institute for Advanced Biosciences; and Université Grenoble Alpes, CEA, LETI, DTBS, LS2P.
Dot A; From the Service de Chirurgie Maxillo-faciale, Centre Hospitalier d'Annecy Genevois; INSERM-UGA U1209, CNRS UMR5309, Institute for Advanced Biosciences; and Université Grenoble Alpes, CEA, LETI, DTBS, LS2P.
Bettega G; From the Service de Chirurgie Maxillo-faciale, Centre Hospitalier d'Annecy Genevois; INSERM-UGA U1209, CNRS UMR5309, Institute for Advanced Biosciences; and Université Grenoble Alpes, CEA, LETI, DTBS, LS2P.
Pokaż więcej
Źródło :
Plastic and reconstructive surgery [Plast Reconstr Surg] 2020 Nov; Vol. 146 (5), pp. 565e-577e.
Typ publikacji :
Journal Article
MeSH Terms :
Arterial Occlusive Diseases/*diagnosis
Graft Rejection/*prevention & control
Monitoring, Physiologic/*methods
Myocutaneous Flap/*blood supply
Reconstructive Surgical Procedures/*adverse effects
Animals ; Arterial Occlusive Diseases/etiology ; Arterial Occlusive Diseases/pathology ; Arteries/pathology ; Diagnosis, Differential ; Disease Models, Animal ; Graft Rejection/diagnosis ; Graft Rejection/etiology ; Humans ; Monitoring, Physiologic/instrumentation ; Myocutaneous Flap/transplantation ; Oxyhemoglobins/analysis ; Reconstructive Surgical Procedures/methods ; Spectroscopy, Near-Infrared/instrumentation ; Spectroscopy, Near-Infrared/methods ; Sus scrofa ; Veins/pathology
Czasopismo naukowe
Tytuł :
Memory T Cells in Transplantation: Old Challenges Define New Directions.
Autorzy :
Nicosia M; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
Fairchild RL
Valujskikh A
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2020 Oct; Vol. 104 (10), pp. 2024-2034.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Adaptive Immunity*/drug effects
Graft Survival*/drug effects
Immunologic Memory*/drug effects
Organ Transplantation*/adverse effects
Transplantation Tolerance*/drug effects
Graft Rejection/*immunology
T-Lymphocytes/*immunology
Animals ; Graft Rejection/blood ; Graft Rejection/prevention & control ; Humans ; Immunosuppressive Agents/therapeutic use ; Phenotype ; T-Lymphocytes/drug effects ; T-Lymphocytes/metabolism ; Treatment Outcome
Czasopismo naukowe
Tytuł :
The Implications of B-lineage Cells in Kidney Allografts.
Autorzy :
Filippone EJ; Division of Nephrology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.; Department of Medicine, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
Farber JL; Department of Pathology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2020 Oct; Vol. 104 (10), pp. 2011-2023.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Cell Lineage*
Graft Survival*/drug effects
Kidney Transplantation*/adverse effects
B-Lymphocytes/*immunology
Graft Rejection/*immunology
Plasma Cells/*immunology
Animals ; B-Lymphocytes/drug effects ; B-Lymphocytes/metabolism ; Graft Rejection/blood ; Graft Rejection/prevention & control ; Humans ; Immunosuppressive Agents/therapeutic use ; Phenotype ; Plasma Cells/drug effects ; Plasma Cells/metabolism ; Treatment Outcome
Czasopismo naukowe
Tytuł :
The Influence of Antithymocyte Globulin Dose on the Incidence of CMV Infection in High-risk Kidney Transplant Recipients Without Pharmacological Prophylaxis.
Autorzy :
de Paula MI; Department of Nephrology, Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil.; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Bae S; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.; Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD.; Department of Biostatistics, Johns Hopkins School of Public Health, Baltimore, MD.
Shaffer AA; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.; Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD.
Garonzik-Wang J; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Felipe CR; Department of Nephrology, Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil.
Cristelli MP; Department of Nephrology, Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil.
Waldram MM; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Massie AB; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.; Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD.
Medina-Pestana J; Department of Nephrology, Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil.
Segev DL; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.; Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD.
Tedesco-Silva H; Department of Nephrology, Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil.
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2020 Oct; Vol. 104 (10), pp. 2139-2147.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Kidney Transplantation*/adverse effects
Kidney Transplantation*/mortality
Antilymphocyte Serum/*administration & dosage
Cytomegalovirus Infections/*prevention & control
Graft Rejection/*prevention & control
Immunosuppressive Agents/*administration & dosage
Adult ; Antilymphocyte Serum/adverse effects ; Brazil ; Cytomegalovirus Infections/immunology ; Cytomegalovirus Infections/mortality ; Female ; Graft Rejection/immunology ; Graft Rejection/mortality ; Graft Survival ; Humans ; Immunocompromised Host ; Immunosuppressive Agents/adverse effects ; Incidence ; Male ; Middle Aged ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Does a Useful Test Exist to Properly Evaluate the Pathogenicity of Donor-specific Antibodies? Lessons From a Comprehensive Analysis in a Well-studied Single-center Kidney Transplant Cohort.
Autorzy :
Gautier Vargas G; Nephrology-Transplantation Department, University Hospital, Strasbourg, France.
Olagne J; Nephrology-Transplantation Department, University Hospital, Strasbourg, France.; Department of Pathology, University Hospital, Strasbourg, France.
Parissiadis A; Histocompatibility Laboratory, UMR-S949 Inserm, Etablissement Français du Sang, Strasbourg, France.
Joly M; Nephrology-Transplantation Department, University Hospital, Strasbourg, France.
Cognard N; Nephrology-Transplantation Department, University Hospital, Strasbourg, France.
Perrin P; Nephrology-Transplantation Department, University Hospital, Strasbourg, France.
Froelich N; Histocompatibility Laboratory, UMR-S949 Inserm, Etablissement Français du Sang, Strasbourg, France.
Guntz P; Histocompatibility Laboratory, UMR-S949 Inserm, Etablissement Français du Sang, Strasbourg, France.
Gachet C; Histocompatibility Laboratory, UMR-S949 Inserm, Etablissement Français du Sang, Strasbourg, France.
Moulin B; Nephrology-Transplantation Department, University Hospital, Strasbourg, France.; INSERM UMR_S 1109, ImmunoRhumatologie Moléculaire, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg, Institut d'Immunologie et d'Hématologie, Strasbourg, France.
Caillard S; Nephrology-Transplantation Department, University Hospital, Strasbourg, France.; INSERM UMR_S 1109, ImmunoRhumatologie Moléculaire, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg, Institut d'Immunologie et d'Hématologie, Strasbourg, France.
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2020 Oct; Vol. 104 (10), pp. 2148-2157.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Complement Fixation Tests*
Monitoring, Immunologic*
Graft Rejection/*diagnosis
HLA Antigens/*immunology
Isoantibodies/*blood
Kidney Transplantation/*adverse effects
Adolescent ; Adult ; Aged ; Biomarkers/blood ; Biopsy ; Child ; Child, Preschool ; Complement C1q/immunology ; Complement C3d/immunology ; Female ; Graft Rejection/blood ; Graft Rejection/immunology ; Graft Survival ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Reproducibility of Results ; Retrospective Studies ; Time Factors ; Treatment Outcome ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies